BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4733347)

  • 1. [Clinical picture and pathogenesis of recurrent erysepilas].
    Schneider I
    Hautarzt; 1973 Apr; 24(4):145-9. PubMed ID: 4733347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic and prognostic significance of some parameters of nonspecific defense humoral mechanism in patients with lymphedema complicated by erysipelas inflammation].
    Elagina LV; Savchenko TV; Pavlova MV
    Klin Med (Mosk); 1998; 76(1):25-7. PubMed ID: 9532910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphographic studies on recurring erysipelas].
    Thury G; Schneider I
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Feb; 116(2):238-45. PubMed ID: 4336194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erysipelas and lymphedema--egg or hen?].
    Stöberl C; Partsch H
    Z Hautkr; 1987 Jan; 62(1):56-62. PubMed ID: 3577282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical picture, immunology and pathogenesis of recurring erysipelas].
    Schneider I
    Z Hautkr; 1986 Apr; 61(7):431-5. PubMed ID: 3705665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erysipelas after breast cancer treatment].
    Ben Salah H; Siala W; Maaloul I; Bouzid F; Frikha M; Daoud J
    Tunis Med; 2002 Aug; 80(8):465-8. PubMed ID: 12703126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte migration test in recurrent erysipelas.
    Dobozy A; Schneider I; Hunyadi J; Simon N
    Acta Derm Venereol; 1973; 53(1):35-8. PubMed ID: 4120805
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphedema of the hand following recurrent erysipelas secondary to fissured irritant contact dermatitis.
    Proske S; Uter W; Schwanitz HJ
    Contact Dermatitis; 2000 Jun; 42(6):368-9. PubMed ID: 10871118
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histologic studies on the skin of patients with recurrent erysipelas].
    Schneider I; Czakó F
    Dermatol Monatsschr; 1972 Mar; 158(3):173-80. PubMed ID: 5032919
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histologic studies of the prefascial lymphatic vessels in recurrent erysipelas].
    Schneider I; Thury G
    Dermatol Monatsschr; 1972 Mar; 158(3):181-9. PubMed ID: 5032920
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent erysipelas caused by group B streptococcus organisms.
    Binnick AN; Klein RB; Baughman RD
    Arch Dermatol; 1980 Jul; 116(7):798-9. PubMed ID: 6772113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of recurring erysipelas].
    Herrmann WP; Reinhold M
    Dtsch Med Wochenschr; 1982 Mar; 107(11):428-9. PubMed ID: 6800755
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of clinical, immunogenetic and immunological indices for predicting the development of the recurrent form of erysipelas of the lower limbs].
    Ambalov IuM; Levina LD; Kovalenko AP
    Lik Sprava; 1992 Sep; (9):60-5. PubMed ID: 1481508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiology, pathogenesis and treatment of severe recurrent forms of erysipelas of the lower extremities].
    Podoprigora AP; Polishchuk IuIe; Slabinskiĭ VV; Podoprigora SP; Podoprigora OV; Poddubnyĭ AV
    Klin Khir; 1998; (7):36-8. PubMed ID: 9989088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis and principles of conservative and surgical treatment of recurrent erysipelas].
    Kosenkov AN; Narenkov VM
    Khirurgiia (Mosk); 2005; (7):63-5. PubMed ID: 16196162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Predisposing and triggering factors in erysipelas].
    Santos I; Andrade Lima MB; Andrade Lima BP
    Med Cutan Ibero Lat Am; 1984; 12(5):399-402. PubMed ID: 6396465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of leukocytic migratory activity indices in patients with erysipelas].
    iudina IuV; Belaia OF
    Klin Lab Diagn; 2008 May; (5):47-9. PubMed ID: 18590169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Necrotizing erysipelas--connections with angiological diseases].
    Schultz-Ehrenburg U; Weindorf N; Tourbier H
    Z Hautkr; 1982 Dec; 57(23):1733-44. PubMed ID: 7164532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erysipelas and lymphangitis in patients undergoing lymphedema treatment after breast-cancer therapy.
    Pereira de Godoy JM; Azoubel LM; Guerreiro Godoy Mde F
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Jun; 18(2):63-5. PubMed ID: 19588059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infectious complications of lymphedema].
    Vaillant L; Gironet N
    Rev Med Interne; 2002 Jun; 23 Suppl 3():403s-407s. PubMed ID: 12162204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.